Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03318016 · TERMINATED
Trial details
- NCT number
- NCT03318016
- Sponsor
- University of Colorado, Denver
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2020-01-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.